Immuron IMRN
NASDAQ IMRN
$1.17 -0.02 (-1.68%)
As of: Sep 30, 2026 · 11:55 AM EDT

Immuron (IMRN) Revenue (2016 - 2024)

Updated

Immuron's Revenue was $7.71 million in FY2026 (year ended Aug 28, 2026), compared with $72,870 in FY2025.

Analysis

Immuron (IMRN) Revenue (2016 - 2024) Analysis & Trends

From FY2015 onward, Immuron has reported Revenue for 12 fiscal years.

  • Revenue shows a five-year compound annual growth rate of 135.4% (FY2021 to FY2026).
  • The FY2026 figure marks the highest annual Revenue in data going back to FY2015.
  • Per Business Quant data, Revenue in earlier fiscal years was $72,870 in FY2025, $49,029 in FY2024 (-97.9%), $2.36 million in FY2023 (+303.6%) and $583,646 in FY2022 (+446.9%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 Immuron 9.36 Mn -7.94 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 9, 2024 32,669.51
Dec 31, 2023 716,561.50
Dec 31, 2022 6.37 Bn
Jun 30, 2016 862,831.81
API Access

Immuron Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=IMRN&period=max&api_key=YOUR_API_KEY